Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

Data as of Oct 20
 -0.11 / -5.14%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company. It is focused on the development of SCENESSE, its proprietary photoprotective drug. The company also focuses on developing drugs for the treatment of severe skin disorders. Clinuvel Pharmaceuticals was founded on December 14, 1999 and is headquartered in Melbourne, Australia.

Contact Information

Clinuvel Pharmaceuticals Ltd.
190 Queen Street
Melbourne Victoria (vic) 3000
P:(139) 660-4900
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Philippe J. WolgenChief Executive Officer, Director & MD
Darren M. KeamyChief Financial Officer & Secretary
Dennis J. WrightChief Scientific Officer
Lachlan HayMedia Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.